Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.
This corporate disclosure from was processed by Pulse News Wire on February 18, 2026. It represents a primary source document for Japanese Corporate sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.
Source disclosure: February 18, 2026 CanBas Co.,Ltd. [4575.T] TOKYO, Feb 18 (Pulse News Wire) – Canbas CO.,LTD. (4575.T) reported a lower net profit of ¥--¥568 million for the quarter ending June 2026, compared ¥88 million in the same period last year. The losses were primarily attributed to ongoing clinical development investments for its lead compound, CBP501, which includes expenses related to preparing for the European Phase III trial application. The company's research and deve